Skip to main content
MPLTSector not reported

MapLight Therapeutics, Inc. (MPLT) Insider Trading

In the last 90 days, 6 MapLight Therapeutics, Inc. (MPLT) insiders reported no open-market purchases and 8 sales totaling $1,533,140. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 15, 2026Anatol KreitzerChief Discovery OfficerSale12,248$7.84$96,024
Oct 15, 2026Erin Pennock FoffChief Medical OfficerSale15,355$8.08$124,068
Oct 15, 2026Kristopher HansonGeneral CounselSale9,020$8.08$72,882
Oct 15, 2026James Woodruff LillieChief Scientific OfficerSale11,513$8.08$93,025
Oct 15, 2026Jonathan GillisCAO and Interim CFOSale10,167$8.08$82,149
Oct 15, 2026Christopher A. KroegerChief Executive OfficerSale73,691$8.08$595,423
Sep 16, 2026Kristopher HansonGeneral CounselSale16,509$11.67$192,660
Aug 3, 2026James Woodruff LillieChief Scientific OfficerSale22,082$12.54$276,908
Jul 28, 2026Troy CoxDirectorOpen Market Purchase15,620$9.52$148,702
Jul 17, 2026Anatol KreitzerChief Discovery OfficerSale36,284$37.09$1,345,893

Common questions

MPLT insider trading FAQ

Are MPLT insiders buying or selling?
Over the last 90 days, MPLT insiders were net sellers, reporting $0.00 of open-market purchases and $1,533,140 of sales.
When was the last MPLT insider purchase?
No open-market insider purchase of MapLight Therapeutics, Inc. stock was reported in the last 90 days.
Where does MPLT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that MapLight Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.